2022 ACIP Updates for Immunizations in Adults and Children: What Pharmacists Need to Know
Can I get a third COVID-19 shot if I am immunocompromised? - Carolina Public Press
Schepisi: Murphy Administration Won't Admit They're Considering New Vaccine Requirements for School Children | SenateNJ.com
Immunization: Vaccine Updates Beyond COVID-19 - Pharmacy Practice News
Homologous and Heterologous Covid-19 Booster Vaccinations | NEJM
June 23, 2021 ACIP Meeting - Welcome & Coronavirus Disease 2019 (COVID-19) Vaccines - YouTube
Advisory Committee on Immunization Practices (ACIP) | CDC
Tell the FDA we need boosters authorized based on scientific evidence.
COVID-19 Vaccine: FAQs, Informational Slides and List of Resources | iCare Management
CDC Presentation
IAC Express # 1,597: Watch ACIP meeting Nov 2–3.
Moderna COVID-19 Vaccine (Spikevax) Approval
How are States Prioritizing Who Will Get the COVID-19 Vaccine First? | KFF
Demonstrating the value of vaccines: global NITAG and HTA requirements - PRMA Consulting
Anne Sosin on Twitter: "Sharp racial disparities in COVID-19 outcomes in kids underscore the importance of centering equity in the 5-11 vaccine rollout as well as in setting equitable, data-driven endpoints for
COVID-19 Vaccine Planning
Booster Doses vs Additional Doses
Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC ...
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022 | MMWR
CDC Presentation
Safety Facts for Providers
Highlights: What Pharmacists Need to Know about ACIP's Latest 2023 Vaccination Schedule Updates
What you need to know: Minnesota's vaccine distribution plan | MPR News
Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021–February 2022, VISION Network: a retrospective cohort study - The Lancet Regional
